Anne-Marie Halland

Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu

Joel M. Kremer, Ricardo Blanco, Marek Brzosko et al. · Arthritis & Rheumatism · 2010 · 410 citations

Tocilizumab Inhibits Structural Joint Damage and Improves Physical Function in Patients with Rheumatoid Arthritis and Inadequate Responses to Methotrexate: LITHE Study 2-year Results

Roy Fleischmann, Anne-Marie Halland, Marek Brzosko et al. · The Journal of Rheumatology · 2013 · 121 citations · Full text

Musculoskeletal manifestations in hyperlipidaemia: a controlled study.

P Klemp, Anne-Marie Halland, F L Majoos et al. · Annals of the Rheumatic Diseases · 1993 · 89 citations · Full text

Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial.

Joel M. Kremer, Ricardo Blanco, Anne-Marie Halland et al. · PubMed · 2016 · 25 citations